{"id":1291,"date":"2018-08-27T10:02:53","date_gmt":"2018-08-27T01:02:53","guid":{"rendered":"http:\/\/urology.dept.med.gunma-u.ac.jp\/?p=1291"},"modified":"2018-08-27T11:51:15","modified_gmt":"2018-08-27T02:51:15","slug":"2014%e5%b9%b4%e3%80%80%e6%a5%ad%e7%b8%be%e3%83%bb%e8%ab%96%e6%96%87","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=1291","title":{"rendered":"2014\u5e74"},"content":{"rendered":"
\n
\u3010\u6559\u5ba4\u696d\u7e3e\u3011<\/dt>\n
Arai S, Matsui H, Ohki R, Miyazawa Y, Koike H, Hashita T, Katsuyama Y, Sekine Y, Nomura \tM, Shibata Y, Hatori M, Ito K, Yamamoto K, Ohmori S and Suzuki K.\uff1aSuicide attempt with an overdose of sunitinib.. Br J Clin Pharmacol; 78(4):933-935, 2014.<\/dd>\n
Ito K.\uff1aProstate cancer in Asian men.. Nature Reviews Urology; 11(4):197-212,2014.<\/dd>\n
Ito K, Fujizuka Y, Ishikura K and Cook B.\uff1aNext-generation prostate-specific antigen test: precursor form of prostate-specific antigen.. Int J Clin Oncol; 19(5):782-792, 2014.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u764c\u306e\u8a3a\u65ad\uff1aPSA\u691c\u8a3a. \u81e8\u5e8a\u6ccc\u5c3f\u5668\u79d12014\u5e74\u5897\u520a; 68(4):49-53, 2014.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u5c02\u9580\u533b\u8cc7\u683c\u8a66\u9a13\u50be\u5411\u3068\u5bfe\u7b56\uff1a\u524d\u7acb\u817a\u80a5\u5927\u75c7\u95a2\u9023. Prostate Journal; 1(1):143-148, 2014.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u65e5\u672c\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u764c\u691c\u8a3a\u306e\u5728\u308a\u65b9, PRO&CON PROS \u2015\u6ccc\u5c3f\u5668\u79d1\u81e8\u5e8a\u533b\u304b\u3089\u898b\u305f\u9069\u5207\u306a\u524d\u7acb\u817a\u764c\u691c\u8a3a\u306e\u65b9\u5411\u6027\u2015. \u764c\u3068\u5316\u5b66\u7642\u6cd5; 41(5):545-552, 2014.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306e\u53d7\u8a3a\u5bfe\u8c61\u5e74\u9f62\u3068\u691c\u8a3a\u9593\u9694\u306e\u65b9\u5411\u6027\u3092\u8003\u3048\u308b\uff1a\u691c\u8a3a\u53d7\u8a3a\u5e74\u9f62\u3068\u691c\u8a3a\u9593\u9694\u306b\u95a2\u3059\u308b\u6700\u65b0\u8ad6\u6587\u306e\u6982\u8981\u3068\u89e3\u91c8\u3000PSA\u691c\u8a3a\u306e\u6709\u52b9\u6027\u3092\u4fdd\u3061\u306a\u304c\u3089\u904e\u5270\u8a3a\u65ad\u3092\u6e1b\u3089\u3059\u691c\u8a3a\u30b7\u30b9\u30c6\u30e0\u306e\u8a2d\u5b9a\u306b\u95a2\u3059\u308b\u30e2\u30c7\u30eb\u5206\u6790\u306b\u95a2\u3059\u308b\u6587\u732e\u30d3\u30e5\u30fc\u3068\u691c\u8a3a\u30b7\u30b9\u30c6\u30e0\u306e\u65b9\u5411\u6027. \u6ccc\u5c3f\u5668\u5916\u79d1; 27(8):1417-1419, 2014.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u5185\u79d1\u533b\u304c\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u524d\u7acb\u817a\u304c\u3093\uff1aPSA\u691c\u8a3a\u306f\u306a\u305c\u65e5\u672c\u4eba\u306b\u5fc5\u8981\u304b. Mebio; 31(9):16-21, 2014.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u9ad8\u9f62\u8005\u306b\u304a\u3051\u308b\u6392\u5c3f\u969c\u5bb3\uff1a\u6392\u5c3f\u969c\u5bb3\u3068\u524d\u7acb\u817a\u7279\u7570\u6297\u539f(PSA)\u306e\u95a2\u4fc2\u306b\u3064\u3044\u3066\u6559\u3048\u3066\u304f\u3060\u3055\u3044. \u8001\u5e74\u533b\u5b66; 52(9):1089-1092, 2014.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u5c02\u9580\u533b\u8cc7\u683c\u8a66\u9a132013\u5e74\u5ea6\u89e3\u8aac\uff1a\u524d\u7acb\u817a\u764c\u95a2\u9023. Prostate Journal; 1(2):295-304, 2014\u5e74.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u6cbb\u7642\u306e\u9032\u6b69\uff1a\u6cbb\u7642\u6cd5\u6c7a\u5b9a\u306e\u305f\u3081\u306e\u524d\u7acb\u817a\u304c\u3093\u81e8\u5e8a\u75c5\u671f\u5206\u985e\u3068\u30ea\u30b9\u30af\u8a3a\u65ad\u3000. \u81e8\u5e8a\u816b\u760d\u30d7\u30e9\u30af\u30c6\u30a3\u30b9; 10(4):405-415, 2014.<\/dd>\n
\u4f0a\u85e4\u4e00\u4eba\uff1a\u53bb\u52e2\u62b5\u6297\u6027\u524d\u7acb\u817a\u764c\uff1a\u524d\u7acb\u817a\u764c\u691c\u8a3a\u306e\u73fe\u6cc1\u3068\u8ab2\u984c. \u65e5\u672c\u81e8\u7240; 72(12):2198-2203, 2014.<\/dd>\n
Koike H, Nitta T, Sekine Y, Arai S, Furuya Y, Nomura M, Matsui H, Shibata Y, Ito K, Oyama T and Suzuki K.\uff1aYM155 reverses rapamycin resistance in renal cancer by decreasing survivin.. J Cancer Res Clin Oncol; 140(10):1705-1713, 2014.<\/dd>\n
\u67f4\u7530\u5eb7\u535a\u3001\u5927\u5c71\u88d5\u4eae\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u9234\u6728\u548c\u6d69\uff1a\u7fa4\u99ac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u6ccc\u5c3f\u5668\u79d1\u306b\u304a\u3051\u308b\u7537\u6027\u4e0d\u598a\u75c7\u307e\u305f\u306f\u9670\u56a2\u75db\u3092\u4e3b\u8a34\u3068\u3059\u308b\u7cbe\u7d22\u9759\u8108\u7624\u306b\u5bfe\u3059\u308b\u9855\u5fae\u93e1\u4e0b\u4f4e\u4f4d\u7d50\u7d2e\u8853\u306e\u691c\u8a0e. Kitakanto Med J; 64(1):31-35, 2014.<\/dd>\n
\u9234\u6728\u548c\u6d69\uff1a\u6cbb\u7642\u306b\u304a\u3051\u308b\u6700\u8fd1\u306e\u65b0\u85ac\u306e\u4f4d\u7f6e\u4ed8\u3051<\u85ac\u52b9\u5225>\uff5e\u65b0\u85ac\u306e\u5e83\u5834\uff5e\u3000\u8180\u80f1\u764c\u30fb\u524d\u7acb\u817a\u764c\u6cbb\u7642\u85ac. \u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb; 50(S-1):390-396, 2014.<\/dd>\n
\u9234\u6728\u548c\u6d69\uff1a\u9032\u5316\u3059\u308b\u53bb\u52e2\u62b5\u6297\u6027\u524d\u7acb\u817a\u764c\u306e\u6cbb\u7642\u6226\u7565. Urology Today; 21(1):4-8, 2014.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\uff1a\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u30db\u30eb\u30e2\u30f3\u7642\u6cd5\u2015intracrinology\u304b\u3089\u307f\u305f\u524d\u7acb\u817a\u764c\u306e\u30d0\u30a4\u30aa\u30ed\u30b8\u30fc\u2015. \u5185\u5206\u6ccc\u306b\u95a2\u3059\u308b\u6700\u65b0\u60c5\u5831: pp.1-8,\u516c\u76ca\u8ca1\u56e3\u6cd5\u4eba\u5c71\u53e3\u5185\u5206\u6ccc\u75be\u60a3\u7814\u7a76\u632f\u8208\u8ca1, 2014.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u677e\u4e95\u3000\u535a\u3001\u52a0\u85e4\u5f18\u4e4b\uff1a\u524d\u7acb\u817a\u764c\u306e\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642. \u81e8\u5e8a\u6ccc\u5c3f\u5668\u79d1; 68(4):306-310, 2014.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u9ad8\u6a4b\u4fca\u4e8c\u3001\u4e0a\u6751\u535a\u53f8\u3001\u677e\u5c71\u8c6a\u6cf0\uff1a\u5ea7\u8ac7\u4f1a\u3000\u53bb\u52e2\u62b5\u6297\u6027\u524d\u7acb\u817a\u764c\u6cbb\u7642\u306b\u304a\u3051\u308b\u30bf\u30ad\u30b5\u30f3\u88fd\u5264\u3078\u306e\u671f\u5f85. Prostate Journal; 1(2):231-236, 2014.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u677e\u4e95\u3000\u535a\u3001\u52a0\u85e4\u5f18\u4e4b\uff1a\u7279\u96c6 \u9032\u5316\u3059\u308b\u524d\u7acb\u817a\u764c\u6cbb\u7642\u3000\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u30c8\u30d4\u30c3\u30af\u30b9. Medicament News; 2177:6-7, (\u682a)\u30e9\u30a4\u30d5\u30fb\u30b5\u30a4\u30a8\u30f3\u30b9, 2014.<\/dd>\n
\u9234\u6728\u548c\u6d69\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u677e\u4e95\u3000\u535a\uff1a\u53bb\u52e2\u62b5\u6297\u6027\u524d\u7acb\u817a\u764c\u3068\u8102\u8cea\u4ee3\u8b1d. \u65e5\u672c\u81e8\u7240; 72(12):2116-2120, 2014.<\/dd>\n
\u5bae\u6fa4\u6176\u884c\u3001\u51a8\u7530\u5065\u4ecb\u3001\u67f4\u7530\u5eb7\u535a\u3001\u9234\u6728\u548c\u6d69\u3001\u4e95\u4e0a\u96c5\u6674\u3001\u6b66\u4e95\u667a\u5e78\uff1a\u6162\u6027\u9aa8\u9ac4\u6027\u767d\u8840\u75c5\u306b\u4f34\u3046\u6301\u7d9a\u52c3\u8d77\u75c7. \u81e8\u5e8a\u6ccc\u5c3f\u5668\u79d1; 68(7):523-526, 2014.<\/dd>\n
\u3010\u8ffd\u52a0\u8ad6\u6587\u3011<\/dt>\n
Igawa T, Takehara K, Onita T, Ito K and Sakai H.\uff1aStability of [-2]Pro-PSA in whole blood and serum: analysis for optimal measurement conditions.. J Clin Lab Anal; 28(4):315-319, 2014.<\/dd>\n
Ishizuka T, Hisada T, Hatori M, Koike A, Hanabuchi K, Matsuzaki S, Kamide Y, Utsugi M, Aoki H, Yoshino R, Yanagitani N, Koga Y, Ono A, Kaira K, Sunaga N, Dobashi K, Tsuburai T, Akiyama K, Yamada M, Suzuki K and Mori M.. Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma.. Inflamm Res; 63(9):789-796, 2014.<\/dd>\n
Onozawa M, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, Kitamura T, Suzuki K, Naito S, Namiki M, Nishimura K, Hirao Y and Akaza H.\uff1aRecent trends in the initial therapy for newly diagnosed prostate cancer in Japan.. Jpn J Clin Oncol; 44(10):969-981, 2014.<\/dd>\n
\u718a\u5742\u6587\u6210\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u6751\u4e95\u3000\u52dd\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u5c71\u672c\u3000\u5de7\u3001\u8d64\u5009\u529f\u4e00\u90ce\uff1a\u4eba\u9593\u30c9\u30c3\u30af\u65bd\u8a2d\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30a2\u30f3\u30b1\u30fc\u30c8\u96c6\u8a08\u5831\u544a(\u7b2c\uff18\u56de\u8abf\u67fb\uff09\u2015\u5e73\u621024\u5e74\u5ea6\u2015. \u6ccc\u5c3f\u5668\u5916\u79d1; 27(8):1401-1405, 2014.<\/dd>\n
\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u72e9\u91ce\u3000\u81e8\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u677e\u672c\u623f\u6c5f\u3001\u77f3\u4e95\u79c0\u548c\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a40\u6b73\u4ee3\u524d\u534a\u306ePSA\u57fa\u6e96\u5024\u7a81\u7834\u7387\u3068\u98df\u54c1\u6442\u53d6\u72b6\u6cc1\u3068\u306e\u95a2\u4fc2. \u7fa4\u99ac\u533b\u5b66; 100:155-157, 2014.<\/dd>\n
Kinoshita T, Honma S, Shibata Y, Yamashita K, Watanabe Y, Maekubo H, Okuyama M, Takashima A and Takeshita N.\uff1aAn innovative LC-MS\/MS-based method for determinig CYP17 and CYP19 activity in the adipose tissue of pre- and postmenopausal and ovariectomized women using 13C-labeled steroid substrates.. J Clin Endocrinol Metab; 99(4):1339-1347, 2014.<\/dd>\n
Sawada K, Kitagawa Y, Ito K, Takeda Y, Mizokami A and Namiki M.\uff1aCumulative risk of developing prostate cancer in men with low (?2.0ng\/mL) prostate-specific antigen levels: A population-based screening cohort study in Japan.. Int J Urol; 21(6):560-565, 2014.<\/dd>\n
\u7530\u4e2d\u5553\u5e79\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u5c71\u4e2d\u82f1\u58fd\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u7814\u7a76\u73ed(\u7530\u4e2d\u73ed)\u5e73\u621021\u5e74\u5ea6\u7d50\u679c\u5831\u544a. \u6ccc\u5c3f\u5668\u5916\u79d1; 27(8):1397-1400, 2014.<\/dd>\n
Tamura Y, Ohki K, Nishii M, Ohtuka Y, Miyakubo M, Nomura M, Ito K, Suzuki K and Suzuki K.\uff1aClinicopathological features and outcomes of prostate cancer patients detected using Ningen dock(annual health check-up)system and population-based screening in rural area of Japan.. Ningen Dock International; 2(1):27-34, 2014.<\/dd>\n
Hirama H, Sugimoto M, Ito K, Shiraishi T and Kakehi Y.\uff1aThe impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer:the Japanese multicenter study cohort.. J Cancer Res Clin Oncol; 140(2):257-263, 2014.<\/dd>\n
Magari T, Shibata S, Arai S, Kashiwagi B, Suzuki K and Suzuki K.\uff1aTime-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels.. Asian J Androl; 16(3):457-460, 2014.<\/dd>\n
Matsuyama H, Shimabukuro T, Hara I, Kohjimoto Y, Suzuki K, Koike H, Uemura H, Hayashi T, Ueno M, Kodaira K, Tomita Y, Sakurai T and Shimizu N.\uff1aCombination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer.. Int J Clin Oncol; 19(5):946-954, 2014.<\/dd>\n
Miyoshi Y, Uemura H, Umemoto S, Sakamaki K, Morita S, Suzuki K, Shibata Y, Masumori N, Ichikawa T, Mizokami A, Sugimura Y, Nonomura N, Sakai H, Honma S, Harada M and Kubota T.\uff1aHigh testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.. BMC Cancer; 14:717, 2014.<\/dd>\n
Mukai H, Takahashi S, Nozawa M, Onozawa Y, Miyazaki J, Ohno K, Suzuki K and The TED 11576 investigators.\uff1aPhase\u2160dose-escalation and pharmacokinetic study(TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer.. Cancer Chemother Pharmacol; 73(4):703-710, 2014.<\/dd>\n
\u3010\u305d\u306e\u4ed6\u3011<\/dt>\n
\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u77f3\u4e95\u79c0\u548c\u3001\u66f2\u3000\u53cb\u5f18\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u4eba\u9593\u30c9\u30c3\u30af\u306b\u304a\u3044\u3066\u524d\u7acb\u817a\u304c\u3093\u5bb6\u65cf\u6b74\u3092\u8074\u53d6\u3059\u308b\u3053\u3068\u306e\u91cd\u8981\u6027. \u7fa4\u99ac\u533b\u5b66; 100:159-161, 2014.<\/dd>\n
\u7530\u6751\u82b3\u7f8e\u3001\u5927\u6728\u4e00\u6210\u3001\u5927\u4e95\u3000\u52dd\u3001\u6817\u7530\u3000\u8aa0\u3001\u5c0f\u91ce\u82b3\u5553\u3001\u4f50\u3005\u6728\u9756\u3001\u5ca1\u90e8\u548c\u5f66\uff1a\u9650\u5c40\u6027\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u6065\u9aa8\u5f8c\u5f0f\u6839\u6cbb\u7684\u524d\u7acb\u817a\u5168\u6458\u9664\u8853\u306e\u691c\u8a0e. \u6ccc\u5c3f\u5668\u5916\u79d1; 27(8):1323-1325, 2014.<\/dd>\n
\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u72e9\u91ce\u3000\u81e8\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u6df1\u5800\u80fd\u7acb\uff1a\u4e0b\u90e8\u5c3f\u8def\u75c7\u72b6\u3092\u65e9\u671f\u306b\u8a8d\u3081\u305f\u795e\u7d4c\u75be\u60a3\u75c7\u4f8b\u306e\u691c\u8a0e. \u7fa4\u99ac\u533b\u5b66; 100:195-200, 2014.<\/dd>\n
\u6c60\u7530\u5f13\u6075\u3001\u8302\u6728\u4fca\u4e00\u3001\u898b\u7530\u3000\u5c0a\u3001\u4f0a\u85e4\u73b2\u5b50\u3001\u6b66\u4e95\u6643\u53f8\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u5168\u8eabMRI\u816b\u760d\u30c9\u30c3\u30af\u306e\u6210\u7e3e\u3068\u8ab2\u984c. \u7fa4\u99ac\u533b\u5b66; 100:69-74, 2014.<\/dd>\n
Oh-oka H, Yamada T, Noto H, Umeyama T, Kadekawa K, Ashitomi K, Nishijima S and Sugaya K.\uff1aEffect of carbazochrome sodium sulfonate on refractory chronic prostatitis.. Int J Urol; 21(11):1162-1166, 2014.<\/dd>\n
\u5927\u68ee\u91cd\u5b8f\u3001\u4e2d\u5cf6\u307e\u3086\u3001\u677e\u8c37\u96c5\u751f\u3001\u9ed2\u6fa4\u3000\u529f\uff1aMRI\u753b\u50cf\u306b\u3066\u8133\u5e79\u6897\u585e\u3092\u7591\u308f\u305b\u305f\u4f4e\u8840\u7cd6\u75c7\u4f8b\u306e\u4e00\u4f8b. \u7fa4\u99ac\u533b\u5b66; 100:135-136, 2014.<\/dd>\n
\u5ca1\u5c71\u5409\u9053\u3001\u6a29\u3000\u5be7\u535a\u3001\u6d45\u91ce\u6b63\u5cb3\u3001\u5c0f\u91ce\u82b3\u5553\u3001\u658e\u85e4\u3000\u4fee\u3001\u7167\u4e95\u3000\u6b63\u3001\u6a4b\u672c\u3000\u4fee\u3001\u7f85\u3000\u667a\u9756\uff1a\u30d2\u30c8\u30de\u30b9\u30c8\u7d30\u80de\u306e\u30b5\u30d6\u30bb\u30c3\u30c8\u3068\u6027\u72b6, \u81e8\u5e8a\u514d\u75ab\u30fb\u30a2\u30ec\u30eb\u30ae\u30fc\u79d1; 62(6):633-639, 2014.<\/dd>\n
\u5c0f\u95a2\u967d\u5b50\u3001\u4e95\u51fa\u3000\u5065\u3001\u6a4b\u672c\u7531\u7f8e\u3001\u65b0\u4e95\u5f18\u6075\u3001\u77f3\u4e95\u9999\u7e54\u3001\u95a2\u6839\u771f\u7d00\u3001\u65e5\u8d8a\u6075\u7f8e\u5b50\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u66f2\u3000\u53cb\u5f18\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u524d\u7acb\u817a\u91dd\u751f\u691c\u65b9\u306b\u95a2\u3059\u308b\u8853\u524d\u30fb\u8853\u5f8c\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c \u2015\u624b\u8853\u5ba4\u770b\u8b77\u5e2b\u306e\u8853\u524d\u8a2a\u554f\u306e\u5e74\u6b21\u5909\u5316\u306b\u3064\u3044\u3066\u2015. \u7fa4\u99ac\u533b\u5b66; 100:173-176, 2014.<\/dd>\n
\u72e9\u91ce\u745e\u7a42\u3001\u91d1\u5b50\u7d17\u5e0c\u3001\u4e0a\u6751\u83ef\u7e54\u3001\u9234\u6728\u7f8e\u6c99\u3001\u91d1\u4e95\u662d\u535a\u3001\u5927\u68ee\u91cd\u5b8f\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u6442\u98df\u6a5f\u80fd\u8a13\u7df4\u5bfe\u8c61\u8005\u306e\u50be\u5411\u3068\u305d\u306e\u4e00\u8003\u5bdf. \u7fa4\u99ac\u533b\u5b66; 100:169-171, 2014.<\/dd>\n
\u4e45\u4fdd\u7530\u88d5\u7f8e\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u5009\u7530\u3000\u552f\u3001\u897f\u5c71\u3000\u6075\u3001\u4f50\u85e4\u771f\u8863\u3001\u795e\u4fdd\u670b\u7f8e\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u5f53\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308b\u30d4\u30ed\u30ea\u83cc\u6297\u4f53\u691c\u67fb\u3068\u9664\u83cc\u6cbb\u7642\u3078\u306e\u53d6\u308a\u7d44\u307f. \u7fa4\u99ac\u533b\u5b66; 100:95-97, 2014\u5e74.<\/dd>\n
\u5009\u7530\u3000\u552f\u3001\u897f\u5c71\u3000\u6075\u3001\u6e05\u6c34\u3000\u78a7\u3001\u6a2a\u5c71\u53cb\u91cc\u3001\u6238\u585a\u771f\u5f13\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\t\t\u9ed2\u6fa4\u3000\u529f\uff1a\u5f53\u30bb\u30f3\u30bf\u30fc\u306b\u7279\u5b9a\u4fdd\u5065\u6307\u5c0e\u306e\u6709\u52b9\u6027\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7fa4\u99ac\u533b\u5b66; 100:85-87, 2014.<\/dd>\n
\u4f50\u85e4\u771f\u8863\u3001\u795e\u4fdd\u670b\u7f8e\u3001\u5009\u7530\u3000\u552f\u3001\u897f\u5c71\u3000\u6075\u3001\u4e45\u4fdd\u7530\u88d5\u7f8e\u3001\u6e05\u6c34\u3000\u78a7\u3001\u6a2a\u5c71\u53cb\u91cc\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9ed2\u6fa4\u3000\u529f. \u5229\u7528\u8005\u306e\u671b\u3080\u7279\u5b9a\u4fdd\u5065\u6307\u5c0e\u306e\u691c\u8a0e\u2015\u6700\u7d42\u8a55\u4fa1\u30a2\u30f3\u30b1\u30fc\u30c8\u7d50\u679c\u3088\u308a\u2015
\n\t\t\t\u7fa4\u99ac\u533b\u5b66 100:163-168\u30012014\u5e7410\u6708<\/dd>\n
\u9577\u5869\u6cf0\u8cb4\u3001\u6749\u7530\u8cb4\u5b50\u3001\u539f\u7530\u548c\u5f66\u3001\u4f50\u85e4\u6b66\u654f\u3001\u5409\u539f\u5c0a\u6a39\u3001\u6b66\u5ddd\u5fd7\u592e\u3001\u4f0a\u85e4\u3000\u6075\u3001\u718a\u5742\u6587\u6210\u3001\t\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u677e\u672c\u623f\u6c5f\u3001\u9ed2\u6fa4\u7531\u7f8e\u5b50\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u524d\u7acb\u817a\u304c\u3093\u306e\u8840\u6db2\u691c\u67fb\u3068\u30d6\u30eb\u30fc\u30af\u30ed\u30fc\u30d0\u30fc\u30fb\u30ad\u30e3\u30f3\u30da\u30fc\u30f3\u8a8d\u77e5\u5ea6\u8abf\u67fb\u5831\u544a. \u7fa4\u99ac\u533b\u5b66; 100:177-182, 2014.<\/dd>\n
\u758b\u7530\u4e45\u6075\u3001\u5b89\u85e4\u53cb\u9999\u3001\u6e05\u6c34\u3000\u78a7\u3001\u6a2a\u5c71\u53cb\u91cc\u3001\u9ed2\u7530\u6b63\u5df3\u3001\u4e0a\u539f\u7802\u77e5\u5b50\u3001\u4f4f\u8c37\u4f73\u592e\u3001\u591a\u80e1\u76f4\u4e5f\u3001\t\u5927\u7af9\u798f\u5bff\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u900f\u6790\u60a3\u8005\u3078\u306e\u6804\u990a\u6307\u5c0e\u5b9f\u65bd\u306e\u6709\u7528\u6027. \u7fa4\u99ac\u533b\u5b66; 100:89-90, 2014.<\/dd>\n
\u6a2a\u5c71\u3000\u52c7\u3001\u50b3\u7530\u548c\u6075\u3001\u9ad8\u6a4b\u96c4\u4e00\u3001\u9f4b\u85e4\u5fd7\u4e43\u3001\u95a2\u3000\u96c5\u5f66\u3001\u9ad8\u6a4b\u7406\u6075\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u30e1\u30c7\u30a3\u30ab\u30eb\t\t\u30d5\u30a3\u30c3\u30c8\u30cd\u30b9\u306b\u304a\u3051\u308b\u5165\u4f1a\u6642\u30a2\u30f3\u30b1\u30fc\u30c8\u7d50\u679c\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7fa4\u99ac\u533b\u5b66; 100:81-84, 2014.<\/dd>\n<\/dl>\n","protected":false},"excerpt":{"rendered":"

\u3010\u6559\u5ba4\u696d\u7e3e\u3011 Arai S, Matsui H, Ohki R, Miyazawa Y, Koike H, Hashita T, Katsuyama Y, Sekine Y, Nomura M, Shibata Y, H […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1291","post","type-post","status-publish","format-standard","hentry","category-achievements"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/1291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1291"}],"version-history":[{"count":5,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/1291\/revisions"}],"predecessor-version":[{"id":1315,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/1291\/revisions\/1315"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}